转移性脉络膜黑色素瘤的临床试验
总计14094个结果
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC终止
-
Iovance Biotherapeutics, Inc.主动,不招人
-
Novartis Pharmaceuticals终止
-
F. Stephen Hodi, MDMedImmune LLC完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Biocad主动,不招人黑色素瘤 | 黑色素瘤转移俄罗斯联邦, 白俄罗斯
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer Institute终止
-
Nektar TherapeuticsImaginAb, Inc.撤销
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
BioNTech US Inc.Apexigen, Inc.终止
-
Nantes University HospitalUMR892完全的
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics Inc.完全的
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.终止
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLC未知
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital Heidelberg完全的
-
Hoag Memorial Hospital Presbyterian完全的
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer Society完全的
-
Duke University终止
-
Yale UniversityNovartis终止
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb完全的
-
California Pacific Medical Center Research Institute完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
M.D. Anderson Cancer CenterAventis Pharmaceuticals完全的
-
Molecular Insight Pharmaceuticals, Inc.终止
-
IDEAYA Biosciences招聘中
-
National Cancer Institute (NCI)主动,不招人转移性皮肤黑色素瘤 | 临床 III 期皮肤黑色素瘤 AJCC v8 | 复发性皮肤黑色素瘤 | 临床 IV 期皮肤黑色素瘤 AJCC v8 | 复发性粘膜黑色素瘤 | 转移性粘膜黑色素瘤 | 非皮肤黑色素瘤 | 转移性非皮肤黑色素瘤 | 复发性非皮肤黑色素瘤美国, 加拿大, 爱尔兰
-
California Pacific Medical Center Research InstituteM.D. Anderson Cancer Center招聘中
-
California Pacific Medical Center Research InstituteTesaro, Inc.; Vanderbilt-Ingram Cancer Center; Huntsman Cancer Institute招聘中
-
Hoffmann-La Roche完全的转移性黑色素瘤美国, 加拿大, 比利时, 西班牙, 法国, 俄罗斯联邦, 澳大利亚
-
University of LouisvilleJames Graham Brown Cancer Center主动,不招人